Atypical presentation of extra-skeletal Ewing’s sarcoma in a 57-year-old female – a case report
DOI:
https://doi.org/10.15584/ejcem.2024.3.11Keywords:
Ewing sarcoma, Ewing sarcoma family of tumors primitive neuroectodermal tumor, extra skeletal Ewing sarcomaAbstract
Introduction and aim. Malignant soft tissue tumors exhibiting similar histological and immunohistochemical characteristics to Ewing sarcoma of the bones are referred to as extra-skeletal Ewing sarcoma within the pathology research domain. These tumors fall under the broader classification of Ewing sarcoma family of tumors, which encompasses Ewing sarcoma of the bones, extra-skeletal Ewing sarcoma, and primitive neuroectodermal tumor, the latter demonstrating a more pronounced neural differentiation compared to Ewing sarcoma of the bone. Extra-skeletal Ewing sarcoma stands out as a rare, aggressive, and rapidly growing malignant soft tissue tumor characterized by a notable recurrence rate and a predilection for occurrence in males. The roots of recognizing extra-skeletal Ewing sarcoma trace back to 1975 when Angervall and Enzinger reported the inaugural case. This study aims to underscore the significance of recognizing diverse clinical presentations for precise diagnosis and effective patient care of Extra-skeletal Ewing sarcoma in an elderly patient.
Case description. In the context of our pathology research, a noteworthy case involves a 57-year-old female presenting with a mass in the left iliac fossa. The diagnosis, established through a comprehensive approach involving Imaging, histopathological examination, immunohistochemistry, and molecular studies such as fluorescence in situ hybridization, confirms the nature of the tumor as extra-skeletal Ewing sarcoma. This case adds to the understanding and documentation of this distinct variant through a multi-modal investigative process.
Conclusion. This case report contributes to the existing literature by shedding light on an atypical presentation of extra-skeletal Ewing sarcoma in an older patient. Understanding the varied clinical manifestations and incorporating advanced diagnostic techniques, such as fluorescence in situ hybridization and immunohistochemistry, is pivotal for accurate diagnosis and optimal patient management.
Downloads
References
Wang CC, Schulz MD. Ewing’s sarcoma: a study of fifty cases treated at the Massachusetts General Hospital, 1930-1952 inclusive. N Engl J Med. 1953;248(14):571-576. doi: 10.1056/NEJM195304022481401
Balamuth NJ, Womer RB. Ewing’s sarcoma. Lancet Oncol. 2010;11(2):184-192. doi: 10.1016/S1470-2045(09)70286-4
Angervall L, Enzinger FM. Extraskeletal neoplasm resembling Ewing’s sarcoma. Cancer. 1975;36(1):240-251. doi: 10.1002/1097-0142(197507)36:1<240::aid-cncr2820360127>3.0.co;2-h
Applebaum MA, Worch J, Matthay KK, et al. Clinical features and outcomes in patients with extraskeletal Ewing sarcoma. Cancer. 2011;117(13):3027-3032. doi: 10.1002/cncr.25840
Juurikka K, Butler GS, Salo T, Nyberg P, Åström P. The Role of MMP8 in Cancer: A Systematic Review. Int J Mol Sci. 2019;20(18):4506. doi: 10.3390/ijms20184506.
Pankratjevaite L, Eskandarani HA, Lizdenis P, Saladzinskas Z. Challenges in diagnosing an extraosseous Ewing sarcoma: A case report. Int J Surg Case Rep. 2022;91(106708):106708. doi: 10.1016/j.ijscr.2021.106708
Gaspar N, Hawkins DS, Dirksen U, et al. Ewing sarcoma: Current management and future approaches through collaboration. J Clin Oncol. 2015;33(27):3036-3046. doi: 10.1200/JCO.2014.59.5256
Mcgowan-Jordan J, Hastings R, Moore J. ISCN2020:An International System for Human Cytogenomic Nomeclature (2020)(Cytogenetic and Genome Research ). 2020.
Chai J, Hyuk MD, Phd, Ro JY. PhD The 2020 WHO Classification of Tumours of soft tissue: selected changes and new entities. Adv Anat Pathol. 2021;28(1):44-58. doi: 10.1097/PAP.0000000000000284
Thacker MM, Humble S, Zhang C, Gokaslan ZL, Galindo RL, Wadhwa R. Surgical outcomes for Ewing sarcoma of the spine: A systematic review. Spine. 2010;35:1400-1410.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 European Journal of Clinical and Experimental Medicine

This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.




